pembrolizumab
merck
['swog1512', 'melanoma', 'pembro']
de-escalation for desmoplastic melanoma!!! swog1512 single agent pembrolizumab as single agent showed amazing response! 89% orr and 32% complete response! (n=27) response is literally off the charts in comparison to other tumor types! #aacr23 #swog
Incoming @ The Angeles Clinic and Research Institute Cedars Sinai affiliate with phase 1 interesr. Frmr phase 1 fellow at MD Anderson & faculty UCI. KU Alum.